State Street Corp Vaxart, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Vaxart, Inc. stock. As of the latest transaction made, State Street Corp holds 790,245 shares of VXRT stock, worth $339,805. This represents 0.0% of its overall portfolio holdings.

Number of Shares

790,245

Previous 688,845 14.72%

Holding current value

$339,805

Previous $454,000 28.63%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.41 - $0.94 $41,574 - $95,316	101,400 Added 14.72%	790,245 $324,000
Q4 2024 Feb 14, 2025	BUY	$0.54 - $0.86 $51,138 - $81,442	94,700 Added 15.94%	688,845 $454,000
Q2 2024 Aug 14, 2024	BUY	$0.53 - $1.3 $5,512 - $13,520	10,400 Added 1.78%	594,145 $398,000
Q1 2024 May 15, 2024	BUY	$0.56 - $1.41 $65,632 - $165,252	117,200 Added 25.12%	583,745 $758,000
Q3 2023 Nov 14, 2023	SELL	$0.69 - $0.85 $41,538 - $51,170	-60,200 Reduced 11.43%	466,545 $349,000
Q2 2023 Aug 14, 2023	SELL	$0.6 - $1.41 $1.28 Million - $3 Million	-2,126,874 Reduced 80.15%	526,745 $384,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.25 $181,302 - $319,193	255,355 Added 10.65%	2,653,619 $2.02 Million
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $8.75 Million - $26.1 Million	-11,671,943 Reduced 82.96%	2,398,264 $2.3 Million
Q3 2022 Nov 15, 2022	BUY	$2.09 - $4.5 $2.92 Million - $6.29 Million	1,398,257 Added 11.03%	14,070,207 $30.7 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $3.21 Million - $6.28 Million	-1,189,024 Reduced 8.58%	12,671,950 $44.4 Million
Q1 2022 May 16, 2022	BUY	$4.29 - $6.64 $11.5 Million - $17.8 Million	2,673,332 Added 23.9%	13,860,974 $69.9 Million
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $14.7 Million - $20.3 Million	2,554,787 Added 29.59%	11,187,642 $70.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.67 - $9.8 $7.98 Million - $11.7 Million	1,196,028 Added 16.08%	8,632,855 $68.6 Million
Q2 2021 Aug 16, 2021	SELL	$5.06 - $10.78 $5.31 Million - $11.3 Million	-1,049,474 Reduced 12.37%	7,436,827 $55.7 Million
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $5.41 Million - $22.4 Million	-958,666 Reduced 10.15%	8,486,301 $51.3 Million
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $29.9 Million - $68.1 Million	8,533,449 Added 936.18%	9,444,967 $53.9 Million
Q3 2020 Nov 10, 2020	BUY	$4.78 - $16.97 $626,638 - $2.22 Million	131,096 Added 16.8%	911,518 $6.06 Million
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $1.31 Million - $6.91 Million	780,422 New	780,422 $6.91 Million

Others Institutions Holding VXRT

# of Institutions

102

Shares Held

27.6M

Call Options Held

14.3K

Put Options Held

55.2K

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $54.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Vaxart, Inc. Transaction History